Patent details

EP2217243 Title: GESTAGEN IN COMBINATION WITH AN ESTROGEN AND ONE OR MORE PHARMACEUTICALLY TOLERABLE EXCIPIENTS/CARRIERS FOR LACTOSE-FREE ORAL CONTRACEPTIVE

Basic Information

Publication number:
EP2217243
PCT Application Number:
PCT/EP/2008/008900
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP088474085
PCT Publication Number:
WO/2009/059690
First applicant's nationality:
Translation Language:
EPO Publication Language:
German
English Title of Invention:
GESTAGEN IN COMBINATION WITH AN ESTROGEN AND ONE OR MORE PHARMACEUTICALLY TOLERABLE EXCIPIENTS/CARRIERS FOR LACTOSE-FREE ORAL CONTRACEPTIVE
French Title of Invention:
GESTAGÈNE EN COMBINAISON AVEC UN OESTROGÈNE ET UN OU PLUSIEURS AGENTS AUXILIAIRES/SUPPORTS PHARMACEUTIQUEMENT ACCEPTABLES POUR LA CONTRACEPTION ORALE SANS LACTOSE
German Title of Invention:
GESTAGEN IN KOMBINATION MIT EINEM ESTROGEN UND EINEM ODER MEHREREN PHARMAZEUTISCH ANNEHMBAREN HILFSSTOFFEN/ TRÄGERN ZUR LAKTOSEFREIEN ORALEN KONTRAZEPTION
SPC Number:

Dates

Filing date:
22/10/2008
Grant date:
06/08/2014
EP Publication Date:
06/08/2014
PCT Publication Date:
14/05/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
18/08/2010
EP B1 Publication Date:
06/08/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
22/10/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
22/10/2008
 
 

Name:
Bayer Pharma Aktiengesellschaft
Address:
Müllerstrasse 178, 13353 Berlin, Germany (DE)

Agent

Name:
KIRKPATRICK
From:
15/09/2014
Address:
AVENUE WOLFERS 32, 1310, LA HULPE, Belgium (BE)
To:

Inventor

1

Name:
CLAUSSEN Claus
Address:
Germany (DE)

2

Name:
BÜRGLEN Beate
Address:
Germany (DE)

3

Name:
PFEIFER Manuela
Address:
Germany (DE)

4

Name:
FRICKE Sabine
Address:
Germany (DE)

5

Name:
LADWIG Ralf
Address:
Germany (DE)

Priority

Priority Number:
07021465
Priority Date:
05/11/2007
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
A61K 47/38;

Annual Fees

Annual Fee Due Date:
02/11/2026
Annual Fee Number:
19
Annual Fee Amount:
281 Euro
Expected Payer:
Last Annual Fee Payment Date:
16/10/2025
Last Annual Fee Paid Number:
18
Last Annual Fee Paid Amount:
262 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages